Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...

"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

As gene and cell therapies evolve, these two histone chaperones could be targeted to influence cell identity and potentially guide stem cells into specific lineages. This is key for developing ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

If administered early, gene therapy has the potential to change the medical history of children born with metachromatic leukodystrophy (MLD), a rare and lethal neurodegenerative disease of genetic ...

Explore the advancements in stem cell therapy for neurodegenerative diseases. Discover market size, trends, and growth projections for 2035 with a focus on treatment innovations.

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

Union Minister for Science and Technology Dr Jitendra Singh inspected the various facilities at BRIC-inStem and underscored ...

Market Valued at US$ 1.69 Billion in 2024, Driven by Technological Advancements and Growing Healthcare Investments ...

Doctors and researchers at the University of Nebraska Medical Center are hoping to bring a different therapy that uses a ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...